Amarin Corp. (AMRN) Tops Q2 EPS by 5c
Tweet
Share
E-mail
Get Alerts AMRN Hot Sheet
Price: $14.15 --0%
Financial Fact:
Research and development: 13.49M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Research and development: 13.49M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Amarin Corp. (NASDAQ: AMRN) reported Q2 EPS of $0.01, $0.05 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $67.49 million versus the consensus estimate of $51.02 million.
For earnings history and earnings-related data on Amarin Corp. (AMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Kanen Wealth Management urges Zevia to explore a sale
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
